California State Teachers Retirement System (CalSTRS)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,054
Closed -$404K 3095
2022
Q4
$404K Buy
+27,054
New +$375K ﹤0.01% 2435
2021
Q2
Sell
-33,042
Closed -$242K 3382
2021
Q1
$242K Hold
33,042
﹤0.01% 2825
2020
Q4
$191K Hold
33,042
﹤0.01% 2846
2020
Q3
$196K Buy
33,042
+12,530
+61% +$62K ﹤0.01% 2726
2020
Q2
$106K Buy
+20,512
New +$129K ﹤0.01% 2938
2019
Q2
Sell
-16,787
Closed -$138K 3128
2019
Q1
$138K Hold
16,787
﹤0.01% 2854
2018
Q4
$269K Buy
16,787
+1,127
+7% +$24.8K ﹤0.01% 2627
2018
Q3
$518K Buy
15,660
+105
+0.7% +$2.7K ﹤0.01% 2434
2018
Q2
$352K Buy
+15,555
New +$369K ﹤0.01% 2644
2014
Q2
Sell
-9,333
Closed -$140K 3114
2014
Q1
$140K Hold
9,333
﹤0.01% 2960
2013
Q4
$172K Hold
9,333
﹤0.01% 2921
2013
Q3
$193K Buy
9,333
+291
+3% +$6.66K ﹤0.01% 2870
2013
Q2
$226K Buy
+9,042
New +$387K ﹤0.01% 2784

California State Teachers Retirement System (CalSTRS)'s AVEO Position: Q1 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 27,054 shares — an estimated $404K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in AVEO in Q2 2013 and held it in 13 quarters. The position peaked at $518K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 27,054 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $404K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
  • California State Teachers Retirement System (CalSTRS)'s AVEO Pharmaceuticals, Inc. position peaked at $518K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2023, filed 9 May 2023.